Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042. - Kang YJ; Luo Q; Worthington J; Kelly A; Cuff J; Zalcberg J; Canfell K; Steinberg J (The Lancet regional health. Western Pacific, 2025)